Frederick John Livesey
Fondatore presso Talisman Therapeutics Ltd.
Posizioni attive di Frederick John Livesey
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Talisman Therapeutics Ltd.
 Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - |
Storia della carriera di Frederick John Livesey
Precedenti posizioni note di Frederick John Livesey
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Gen2 Neuroscience Ltd.
 Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Amministratore Delegato | 07/01/2016 | - |
| Fondatore | 07/01/2016 | - |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Founder | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Gen2 Neuroscience Ltd.
Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
